Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking. In addition to lifestyle interventions, lipid-lowering therapy should be considered for persons at moderate to high risk for atherosclerotic cardiovascular disease based on validated risk equations. Statin therapy is the first-line medical treatment for dyslipidemia due to its effectiveness and favorable adverse effect profile, but newer treatments provide additional tools for clinicians to effectively treat dyslipidemia.
Keyphrases
- cardiovascular disease
- physical activity
- coronary artery disease
- weight loss
- metabolic syndrome
- healthcare
- randomized controlled trial
- type diabetes
- cardiovascular events
- body mass index
- systematic review
- smoking cessation
- coronary artery bypass grafting
- emergency department
- cardiovascular risk factors
- blood brain barrier
- mesenchymal stem cells
- body weight
- acute coronary syndrome
- high intensity
- weight gain
- left ventricular